Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response (2014)

  • Authors:
  • USP affiliated authors: SATO, MARIA NOTOMI - FM
  • USP Schools: FM
  • DOI: 10.1371/journal.pone.0099887
  • Subjects: VACINAS VIRAIS; CÉLULAS CULTIVADAS; DOENÇAS AUTOIMUNES
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: PLOS ONE
    • ISSN: 1932-6203
    • Volume/Número/Paginação/Ano: v. 9, n. 6, 11 p. art. e99887, 2014
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1371/journal.pone.0099887 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1371/journal.pone.0099887 (Fonte: Unpaywall API)

    Título do periódico: PLoS ONE

    ISSN: 1932-6203

    • Melhor URL em Acesso Aberto:
      • Página do artigo
      • Evidência: oa journal (via doaj)
      • Licença: cc-by
      • Versão: publishedVersion
      • Tipo de hospedagem: publisher


    • Outras alternativas de URLs em Acesso Aberto:
        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: PLoS ONE

    ISSN: 1932-6203

    Citescore - 2017: 3.01

    SJR - 2017: 1.164

    SNIP - 2017: 1.111


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2495748-10BCSEP 054 2014
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GODINHO, Rodrigo Maciel da Costa; MATASSOLI, Flavio Lemos; LUCAS, Carolina Gonçalves de Oliveira; et al. Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response. PLOS ONE, San Francisco, v. 9, n. 6, p. 11 art. e99887, 2014. Disponível em: < http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0099887&representation=PDF > DOI: 10.1371/journal.pone.0099887.
    • APA

      Godinho, R. M. da C., Matassoli, F. L., Lucas, C. G. de O., Rigato, P. O., Gonçalves, J. L. S., Sato, M. N., et al. (2014). Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response. PLOS ONE, 9( 6), 11 art. e99887. doi:10.1371/journal.pone.0099887
    • NLM

      Godinho RM da C, Matassoli FL, Lucas CG de O, Rigato PO, Gonçalves JLS, Sato MN, Maciel M, Peçanha LMT, August JT, Marques ET de A, Arruda LB de. Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response [Internet]. PLOS ONE. 2014 ; 9( 6): 11 art. e99887.Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0099887&representation=PDF
    • Vancouver

      Godinho RM da C, Matassoli FL, Lucas CG de O, Rigato PO, Gonçalves JLS, Sato MN, Maciel M, Peçanha LMT, August JT, Marques ET de A, Arruda LB de. Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response [Internet]. PLOS ONE. 2014 ; 9( 6): 11 art. e99887.Available from: http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0099887&representation=PDF

    Referências citadas na obra
    Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68 (9): , 6103–6110.
    Ferre AL, Lemongello D, Hunt PW, Morri MM, Garcia JC, et al.. (2010) Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J. Virol. 84 (19), : 10354–10365.
    Owen RE, Heitman JW, Hirschkorn DF, Lanteri MC, Biswas HH, et al.. (2010) HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses. AIDS. 24(8): ,1095–10105.
    Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al.. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68 (7): , 4650–4655.
    Pontesilli O, Klein MR, Kerkhof-Garde SR, Pakker NG, de Wolf F, et al.. (1998) Longitudinal analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte responses: a predominant gag-specific response is associated with nonprogressive infection. J. Infect. Dis. 178(4): , 1008–1018.
    Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, et al.. (1997) Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 278 (5342): ,1447–1450.
    Bertoletti A, Cham F, McAdam S, Rostron T, Rowland-Jones S, et al.. (1998) Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J Virol. Mar. 72(3): , 2439–48.
    Durali D, Morvan J, Letourneur F, Schmitt D, Guegan N, et al.. (1998) Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. J. Virol.72 (5),: 3547–3553.
    McAdam S, Kaleebu P, Krausa P, Goulder P, French N, et al.. (1998) Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection. AIDS. 12 (6): , 571–579.
    Shedlock DJ, Weiner DB (2000) DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 68(6): , 793–806.
    Autor: M Bivas-Benita
    Título: Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol
    Volume: 6(1)
    Primeira página: 156
    Ano: 2012
    Böckl K, Wild J, Bredl S, Kindsmüller K, Köstler J, et al.. (2012) Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine. PLoS One. 7 (4): , e34723.
    Fuller DH, Rajakumar P, Che JW, Narendran A, Nyaundi J, et al.. (2012) Therapeutic DNA vaccine induces broad T cell responses in the gut and sustained protection from viral rebound and AIDS in SIV-infected rhesus macaques. PLoS One. 7 (3): , e33715.
    Pissani F, Malherbe DC, Robins H, Defilippis VR, Park B, et al.. (2012) Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially. Vaccine. 30(37): , 5519–5526.
    Schliehe C, Bitzer A, van den Broek M, Groettrup M (2012) Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo. J. Virol. 86(18): , 9782–9793.
    Felber BK, Hadzopoulou-Cladaras M, Cladaras C, Copeland T, Pavlakis GN (1989) Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86: , 1495–1499.
    Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN (1997) Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71(7): , 4892–4903.
    Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA (2000) A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74 (10): , 4839–4852.
    Ngumbela KC, Ryan KP, Sivamurthy R, Brockman MA, Gandhi RT, et al.. (2008) Quantitative effect of suboptimal codon usage on translational efficiency of mRNA encoding HIV-1 gag in intact T cells. PLoS One. 3(6): ,e2356.
    Qiu JT, Song R, Dettenhofer M, Tian C, August T, et al.. (1999) Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J. Virol. 73(11): ,9145–9152.
    Deml L, Bojak A, Steck S, Graf M, Wild J, et al.. (2001) Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J. Virol. 75 (22): , 10991–11001.
    Bojak A, Wild J, Deml L, Wagner R (2002) Impact of codon usage modification on T cell immunogenicity and longevity of HIV-1 gag-specific DNA vaccines. Intervirology. 45 (4–6): , 275–286.
    Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, et al.. (2010) HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J. Virol. 84 (21): , 11020–11029.
    Maecker HT, Umetsu DT, DeKruyff RH, Levy S (1998) Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol. 161 (12): , 6532–6536.
    Langlade-Demoyen P, Garcia-Pons F, Castiglioni P, Garcia Z, Cardinaud S, et al.. (2003) Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. Eur. J. Immunol. 33 (3): , 720–728.
    Klein MR, van Baalen CA, Holwerda AM, Kerkhof Garde SR, Bende RJ, et al.. (1995) Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181 (4): , 1365–1372.
    Ferre AL, Hunt PW, Critchfield JW, Young DH, Morris MM, et al.. (2009) Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood. 113 (17): , 3978–3989.
    Arruda LB, Sim D, Chikhlikar PR, Maciel M Jr, Akasaki K, et al.. (2006) Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes. J. Immunol. 177 (4): , 2265–2275.
    Kaur M, Rai A, Bhatnagar R (2009) Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challenge. Vaccine. 27 (15): , 2128–2137.
    Midha S, Bhatnagar R (2009) Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses. Eur. J. Immunol. 39 (1): , 159–177.
    Bazhan SI, Karpenko LI, Ilyicheva TN, Belavin PA, Seregin SV, et al.. (2010) Rational design based synthetic polyepitope DNA vaccine for eliciting HIV-specific CD8+ T cell responses. Mol Immunol. 47(7–8): , 1507–1515.
    Wang Q, Lei C, Wan H, Liu Q (2012) Improved cellular immune response elicited by a ubiquitin-fused DNA vaccine against Mycobacterium tuberculosis. DNA Cell. Biol. 31(4): , 489–495.
    Qiu JT, Liu B, Tian C, Pavlakis GN, Yu XF (2000) Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway. J. Virol. 74(13): , 5997–6005.
    Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, et al.. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 166(12): , 7309–7318.
    Clayton A, Turkes A, Navabi H, Mason MD, Tabi Z (2005) Induction of heat shock proteins in B-cell exosomes. J. Cell Sci. 118 (Pt 16): , 3631–3638.
    Zhang H, Xie Y, Li W, Chibbar R, Xiong S, et al.. (2011) CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic T-lymphocyte responses and antitumor immunity. Cell Mol Immunol. 8(1): , 23–30.
    Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, et al.. (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Na.t Med. 4(5): , 594–600.
    Hartman ZC, Wei J, Glass OK, Guo H, Lei G, et al.. (2011) Increasing vaccine potency through exosome antigen targeting. Vaccine. 29 (50): , 9361–9367.
    Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al.. (1996) B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183(3): , 1161–1172.
    Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2(8): , 569–79.
    Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, et al.. (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 7(3): , 297–303.
    Delcayre A, Estelles A, Sperinde J, Roulon T, Paz P, et al.. (2005) Exosome display technology: applications to the development of new diagnostics and therapeutics. Blood Cells Mol. Dis. 35 (2): , 158–168.
    Marques ET Jr, Chikhlikar P, Arruda LB, Leao IC, Lu Y, et al.. (2003) HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses. J. Biol. Chem. 278(39): , 37926–37936.
    Arruda LB, Chikhlikar PR, August JT, Marques ET Jr (2004) DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response. Immunology. 112(1): , 126–133.
    Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, et al.. (1996) Proc. Natl. Acad.Sci. U. S. A. 93: , 14082–14087.
    Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, et al.. (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 273 (32): , 20121–20127.
    Nguyen DG, Booth A, Gould SJ, Hildreth JE (2003) Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278 (52): , 52347–52354.
    Autor: C Dubey
    Título: Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol
    Volume: 155(1)
    Primeira página: 45
    Ano: 1995
    Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. s113 (Pt 19): , 3365–3374.
    Vaccari M, Trindade CJ, Venzon D, Zanetti M, Franchini G (2005) Vaccine-induced CD8+ central memory T cells in protection from simian AIDS. J. Immunol. 175(6): , 3502–3507.
    Letvin NL, Mascola JR, Sun Y, Gorgone DA, Buzby AP, et al.. (2006) Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science. 312 (5779): , 1530–1533.
    Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, et al.. (2010) Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc. Natl. Acad. Sci. USA. 107(21): , 9843–9848.
    Autor: DA Vargas-Inchaustegui
    Título: NK and CD4+ T Cell Cooperative Immune Responses Correlate with Control of Disease in a Macaque Simian Immunodeficiency Virus Infection Model. J Immunol
    Volume: 189(4)
    Primeira página: 1878
    Ano: 2012
    Thakur A, Pedersen LE, Jungersen G (2012) Immune markers and correlates of protection for vaccine induced immune responses. Vaccine. 30(33): , 4907–4920.
    Lu Y, Raviprakash K, Leao IC, Chikhlikar PR, Ewing D, et al.. (2003) Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine. 21(17–18): , 2178–2189.
    Chang DD, Sharp PA (1989) Regulation by HIV Rev depends upon recognition of splice sites. Cell. 59: , 789–795.
    Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, et al.. (1991) Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65: , 5305–5313.
    Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, et al.. (1992) Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1results in Rev-independent gag expression. J. Virol. 66: , 7176–7182.
    Pollard VW, Malim MH (1998) The HIV-1 Rev protein. Annu. Rev. Microbiol. 52: ,491–532.
    Graf M, Bojak A, Deml L, Bieler K, Wolf H, et al.. (2000) Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J. Virol. 74 (22): , 10822–10826.
    Chikhlikar P, Arruda LB, Maciel M Jr, Silvera P, Lewis MG, et al.. (2006) DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques. PLoS One. 1: , e135.
    Fu TM, Ulmer JB, Caulfield MJ, Deck RR, Friedman A, et al.. (1997) Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3 (6): , 362–371.
    Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, et al.. (1998) Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med. 188(6): , 1075–1082.
    Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Chibbar R, et al.. (2011) GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses. Vaccine. 29(19): , 3538–3547.
    Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Xiang J (2012) Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. Vaccine. 30(24): ,3519–3525.
    Stober D, Trobonjaca Z, Reimann J, Schirmbeck R (2002) Dendritic cells pulsed with exogenous hepatitis B surface antigen particles efficiently present epitopes to MHC class I-restricted cytotoxic T cells. Eur. J. Immunol. 32 (4): ., 1099–1108